Mon, April 18, 2022
Sun, April 17, 2022
Thu, April 14, 2022
Wed, April 13, 2022
Tue, April 12, 2022
Mon, April 11, 2022
Sun, April 10, 2022
Fri, April 8, 2022

Matthew Harrison Maintained (ADCT) at Buy with Increased Target to $30 on, Apr 12th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-30-on-apr-12th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Maintained "ADC Therapeutics SA" (ADCT) at Buy with Increased Target from $29 to $30 on, Apr 12th, 2022.

Matthew has made no other calls on ADCT in the last 4 months.



There is 1 other peer that has a rating on ADCT. Out of the 1 peers that are also analyzing ADCT, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $54 on, Friday, March 4th, 2022

Publication Contributing Sources